These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34474062)

  • 1. A Review on Re-Packaging of Bisphosphonates Using Biomaterials.
    Barik D; Dash P; Uma PI; Kumari S; Dash M
    J Pharm Sci; 2021 Dec; 110(12):3757-3772. PubMed ID: 34474062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silk biomaterials in wound healing and skin regeneration therapeutics: From bench to bedside.
    Chouhan D; Mandal BB
    Acta Biomater; 2020 Feb; 103():24-51. PubMed ID: 31805409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in orthopedic applications.
    Wilkinson JM; Little DG
    Bone; 2011 Jul; 49(1):95-102. PubMed ID: 21256254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates and their influence on fracture healing: a systematic review.
    Molvik H; Khan W
    Osteoporos Int; 2015 Apr; 26(4):1251-60. PubMed ID: 25572046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering.
    Ossipov DA
    Expert Opin Drug Deliv; 2015; 12(9):1443-58. PubMed ID: 25739860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials.
    Li YT; Cai HF; Zhang ZL
    Osteoporos Int; 2015 Feb; 26(2):431-41. PubMed ID: 25266485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates: from the laboratory to the clinic and back again.
    Russell RG; Rogers MJ
    Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bisphosphonates in breast and prostate cancers.
    Brown JE; Neville-Webbe H; Coleman RE
    Endocr Relat Cancer; 2004 Jun; 11(2):207-24. PubMed ID: 15163299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.
    Mönkkönen H; Auriola S; Lehenkari P; Kellinsalmi M; Hassinen IE; Vepsäläinen J; Mönkkönen J
    Br J Pharmacol; 2006 Feb; 147(4):437-45. PubMed ID: 16402039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous non-traumatic stress fractures in bilateral femoral shafts in a patient treated with bisphosphonates.
    Shin DY; Ku CR; Kim KM; Choi HS; Rhee Y; Lee EJ; Lim SK
    Korean J Intern Med; 2012 Mar; 27(1):98-102. PubMed ID: 22403507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
    Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
    J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of BMPs and bisphosphonates in improving bone fracture healing.
    Yu NY; Schindeler A; Tagil M; Ruys AJ; Little DG
    Front Biosci (Elite Ed); 2012 Jun; 4(7):2647-53. PubMed ID: 22652667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates.
    McClung MR
    Endocrinol Metab Clin North Am; 2003 Mar; 32(1):253-71. PubMed ID: 12699302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
    Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
    Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone union after spinal fusion surgery using local bone in long-term bisphosphonate users: a prospective comparative study.
    Kang T; Park SY; Hong SH; Lee JH; Lee SH; Park JH
    Arch Osteoporos; 2019 Jun; 14(1):74. PubMed ID: 31256304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do bisphosphonates affect fracture healing?
    Kates SL; Ackert-Bicknell CL
    Injury; 2016 Jan; 47 Suppl 1(0 1):S65-8. PubMed ID: 26768295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed/non-union of upper limb fractures with bisphosphonates: systematic review and recommendations.
    Ng AJ; Yue B; Joseph S; Richardson M
    ANZ J Surg; 2014 Apr; 84(4):218-24. PubMed ID: 24529100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.